ArticleImmunoTargets and therapy2026

Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3).

Sylwia A Stefańczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.